The case for the WHO Advisory Note, Global Nicotine Reduction Strategy

Simple item page
dc.contributor.authorHatsukami, Dorothy K.
dc.contributor.authorZaatari, Ghazi S.
dc.contributor.authorDonny, Eric C.
dc.contributor.departmentPathology and Laboratory Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:09:56Z
dc.date.available2025-01-24T12:09:56Z
dc.date.issued2017
dc.identifier.doihttps://doi.org/10.1136/tobaccocontrol-2016-053134
dc.identifier.eid2-s2.0-84977546383
dc.identifier.pmid27357938
dc.identifier.urihttp://hdl.handle.net/10938/32191
dc.language.isoen
dc.publisherBMJ Publishing Group
dc.relation.ispartofTobacco Control
dc.sourceScopus
dc.subjectHarm reduction
dc.subjectHumans
dc.subjectNicotine
dc.subjectSmoking cessation
dc.subjectSmoking prevention
dc.subjectTobacco products
dc.subjectTobacco smoking
dc.subjectWorld health organization
dc.subjectHuman
dc.subjectPrevention and control
dc.subjectSmoking
dc.subjectTobacco
dc.titleThe case for the WHO Advisory Note, Global Nicotine Reduction Strategy
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2017-9203.pdf
Size:
37.83 KB
Format:
Adobe Portable Document Format
Download

Collections

Pathology and Laboratory Medicine